Literature DB >> 32353108

Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.

Mathilde Payen1,2, Ioannis Nicolis3, Marie Robin4, David Michonneau4,5, Johanne Delannoye1, Camille Mayeur6, Nathalie Kapel1,7, Béatrice Berçot2, Marie-José Butel1, Jérôme Le Goff2,5, Gérard Socié4,5, Clotilde Rousseau1,2.   

Abstract

Acute graft-versus-host disease (aGVHD) is the main complication of hematopoietic stem cell transplantation (HSCT). Changes in gut microbiota composition have been associated with subsequent aGVHD, and reconstitution of healthy microbiota is currently being explored as a therapeutic approach. However, the specific actors in the intestinal ecosystem involved in the pathologic process at the time of aGVHD onset are not yet fully known. We prospectively collected stool samples from patients who underwent allogeneic HSCT. Patients sampled at aGVHD onset were compared with non-GVHD patients. To identify phylogenetic and functional signatures of the disease process, we determined fecal short-chain fatty acid (SFCA) profiles and used high-throughput DNA sequencing and real-time quantitative polymerase chain reaction to assess the microbiota composition. Microbiota alterations were highly specific of gastrointestinal (GI) aGVHD severity. Bacterial biomass and α-diversity were lower in severe aGVHD. We identified several bacterial signatures associated with severe aGVHD at disease onset; a negative correlation was observed with anaerobic bacteria of the Lachnospiraceae, especially the Blautia genus, and Ruminococcaceae families. In parallel, in severe aGVHD patients, we showed a dramatic decrease in the levels of the main SFCAs: acetate (75.8%), propionate (95.8%), and butyrate (94.6%). Mild aGVHD patients were characterized by conserved levels of propionate and Blautia propionate producers. Butyrate was significantly decreased in all GI aGVHD stages, representing a potential diagnostic marker of the disease. Specific microbiota and metabolic alterations were thus associated with aGVHD severity and may be useful for diagnostic and pathophysiologic purposes.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32353108      PMCID: PMC7218439          DOI: 10.1182/bloodadvances.2020001531

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  35 in total

1.  The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

Authors:  Ying Taur; Robert R Jenq; Miguel-Angel Perales; Eric R Littmann; Sejal Morjaria; Lilan Ling; Daniel No; Asia Gobourne; Agnes Viale; Parastoo B Dahi; Doris M Ponce; Juliet N Barker; Sergio Giralt; Marcel van den Brink; Eric G Pamer
Journal:  Blood       Date:  2014-06-17       Impact factor: 22.113

2.  Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.

Authors:  Jonathan U Peled; Antonio L C Gomes; Sean M Devlin; Eric R Littmann; Ying Taur; Anthony D Sung; Daniela Weber; Daigo Hashimoto; Ann E Slingerland; John B Slingerland; Molly Maloy; Annelie G Clurman; Christoph K Stein-Thoeringer; Kate A Markey; Melissa D Docampo; Marina Burgos da Silva; Niloufer Khan; André Gessner; Julia A Messina; Kristi Romero; Meagan V Lew; Amy Bush; Lauren Bohannon; Daniel G Brereton; Emily Fontana; Luigi A Amoretti; Roberta J Wright; Gabriel K Armijo; Yusuke Shono; Míriam Sanchez-Escamilla; Nerea Castillo Flores; Ana Alarcon Tomas; Richard J Lin; Lucrecia Yáñez San Segundo; Gunjan L Shah; Christina Cho; Michael Scordo; Ioannis Politikos; Kasumi Hayasaka; Yuta Hasegawa; Boglarka Gyurkocza; Doris M Ponce; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Robert R Jenq; Takanori Teshima; Nelson J Chao; Ernst Holler; Joao B Xavier; Eric G Pamer; Marcel R M van den Brink
Journal:  N Engl J Med       Date:  2020-02-27       Impact factor: 91.245

Review 3.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-11-30       Impact factor: 91.245

4.  Antibiotic Exposure and Reduced Short Chain Fatty Acid Production after Hematopoietic Stem Cell Transplant.

Authors:  Lindsey E Romick-Rosendale; David B Haslam; Adam Lane; Lee Denson; Kelly Lake; Alyss Wilkey; Miki Watanabe; Stuart Bauer; Bridget Litts; Nathan Luebbering; Christopher E Dandoy; Stella M Davies
Journal:  Biol Blood Marrow Transplant       Date:  2018-07-26       Impact factor: 5.742

5.  Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Ying Taur; Joao B Xavier; Lauren Lipuma; Carles Ubeda; Jenna Goldberg; Asia Gobourne; Yeon Joo Lee; Krista A Dubin; Nicholas D Socci; Agnes Viale; Miguel-Angel Perales; Robert R Jenq; Marcel R M van den Brink; Eric G Pamer
Journal:  Clin Infect Dis       Date:  2012-06-20       Impact factor: 9.079

Review 6.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

7.  Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems.

Authors:  Kim-Anh Lê Cao; Simon Boitard; Philippe Besse
Journal:  BMC Bioinformatics       Date:  2011-06-22       Impact factor: 3.169

8.  Metabolic reconstruction for metagenomic data and its application to the human microbiome.

Authors:  Sahar Abubucker; Nicola Segata; Johannes Goll; Alyxandria M Schubert; Jacques Izard; Brandi L Cantarel; Beltran Rodriguez-Mueller; Jeremy Zucker; Mathangi Thiagarajan; Bernard Henrissat; Owen White; Scott T Kelley; Barbara Methé; Patrick D Schloss; Dirk Gevers; Makedonka Mitreva; Curtis Huttenhower
Journal:  PLoS Comput Biol       Date:  2012-06-13       Impact factor: 4.475

9.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

10.  Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis.

Authors:  Nicholas A Scott; Anna Andrusaite; Peter Andersen; Melissa Lawson; Cristina Alcon-Giner; Charlotte Leclaire; Shabhonam Caim; Gwenaelle Le Gall; Tovah Shaw; James P R Connolly; Andrew J Roe; Hannah Wessel; Alberto Bravo-Blas; Carolyn A Thomson; Verena Kästele; Ping Wang; Daniel A Peterson; Allison Bancroft; Xuhang Li; Richard Grencis; Allan McI Mowat; Lindsay J Hall; Mark A Travis; Simon W F Milling; Elizabeth R Mann
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

View more
  20 in total

1.  [How I treat gastrointestinal tract acute graft versus host disease with fecal microbiota transplantation].

Authors:  X W Tang; D P Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-05-14

2.  Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate.

Authors:  Ruiqing Wang; Xinyu Yang; Jinting Liu; Fang Zhong; Chen Zhang; Yuhong Chen; Tao Sun; Chunyan Ji; Daoxin Ma
Journal:  Nat Commun       Date:  2022-05-09       Impact factor: 17.694

Review 3.  Opportunities and Challenges for Gut Microbiota in Acute Leukemia.

Authors:  Tao Ma; Yan Chen; Li-Juan Li; Lian-Sheng Zhang
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

Review 4.  An Unconventional View of T Cell Reconstitution After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Hana Andrlová; Marcel R M van den Brink; Kate A Markey
Journal:  Front Oncol       Date:  2021-02-18       Impact factor: 6.244

Review 5.  Indole derivatives, microbiome and graft versus host disease.

Authors:  Muna Qayed; David Michonneau; Gerard Socié; Edmund K Waller
Journal:  Curr Opin Immunol       Date:  2021-02-26       Impact factor: 7.268

6.  Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Salvatore Fiorenza; Cameron J Turtle
Journal:  Immunometabolism       Date:  2021-01-12

Review 7.  Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.

Authors:  Tao Hong; Rui Wang; Xiaoqi Wang; Shijie Yang; Weihao Wang; Qiangguo Gao; Xi Zhang
Journal:  Front Immunol       Date:  2021-03-16       Impact factor: 7.561

8.  Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Vitor Heidrich; Julia S Bruno; Franciele H Knebel; Vinícius C de Molla; Wanessa Miranda-Silva; Paula F Asprino; Luciana Tucunduva; Vanderson Rocha; Yana Novis; Celso Arrais-Rodrigues; Eduardo R Fregnani; Anamaria A Camargo
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

Review 9.  Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation.

Authors:  Sarah Lindner; Jonathan U Peled
Journal:  Curr Opin Hematol       Date:  2020-11       Impact factor: 3.218

Review 10.  How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Benoît Vandenhove; Lorenzo Canti; Hélène Schoemans; Yves Beguin; Frédéric Baron; Carlos Graux; Tessa Kerre; Sophie Servais
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.